End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.64 CNY | +2.01% |
|
-0.21% | -38.99% |
05-16 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
04-25 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Chengdu Olymvax Biopharmaceuticals Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688319 Stock
- Consensus Chengdu Olymvax Biopharmaceuticals Inc.